In Vitro-In Vivo Extrapolation Method to Predict Human Renal Clearance of Drugs

被引:31
作者
Kunze, Annett [1 ,2 ]
Huwyler, Joerg [2 ]
Poller, Birk [1 ]
Gutmann, Heike [1 ]
Camenisch, Gian [1 ]
机构
[1] Novartis Inst BioMed Res, Drug Drug Interact Sect, Div Drug Metab & Pharmacokinet, CH-4056 Basel, Switzerland
[2] Univ Basel, Div Pharmaceut Technol, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland
关键词
in vitro-in vivo correlations (IVIVC); renal clearance; renal reabsorption; permeability; drug transport; in vitro models; membrane transport; pharmacokinetics; LLC-PK1 cell line; clearance prediction; TRANSCELLULAR TRANSPORT; MEMBRANE TRANSPORTERS; LLC-PK1; KIDNEY; PARAMETERS; METABOLISM; MECHANISMS; MONOLAYERS; EXPRESSION; MODEL;
D O I
10.1002/jps.23851
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Renal clearance is a key determinant of the elimination of drugs. To date, only few in vitro-in vivo extrapolation (IVIVE) approaches have been described to predict the renal organ clearance as the net result of glomerular filtration, tubular secretion, and tubular reabsorption. In this study, we measured in LLC-PK1 cells the transport of 20 compounds that cover all four classes of the Biopharmaceutical Drug Disposition System. These data were incorporated into a novel kidney model to predict all renal clearance processes in human. We showed that filtration and secretion were main contributors to the renal organ clearance for all compounds, whereas reabsorption was predominant for compounds assigned to classes 1 and 2. Our results suggest that anionic drugs were not significantly secreted in LLC-PK1 cells, resulting in under-predicted clearances. When all study compounds were included a high overall correlation between the reported and predicted renal organ clearances was obtained (R-2 = 0.83). The prediction accuracy in terms of percentage within twofold and threefold error was 70% and 95%, respectively. In conclusion, our novel IVIVE method allowed to predict the human renal organ clearance and the contribution of each underlying process. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:994 / 1001
页数:8
相关论文
共 50 条
  • [21] Albumin-Mediated Uptake Improves Human Clearance Prediction for Hepatic Uptake Transporter Substrates Aiding a Mechanistic In Vitro-In Vivo Extrapolation (IVIVE) Strategy in Discovery Research
    Li, Na
    Badrinarayanan, Akshay
    Ishida, Kazuya
    Li, Xingwen
    Roberts, John
    Wang, Shuai
    Hayashi, Mike
    Gupta, Anshul
    AAPS JOURNAL, 2020, 23 (01)
  • [22] In Vitro-In Vivo Correlation for Low-Clearance Compounds Using Hepatocyte Relay Method
    Di, Li
    Atkinson, Karen
    Orozco, Christine C.
    Funk, Carrie
    Zhang, Hui
    McDonald, Thomas S.
    Tan, Beijing
    Lin, Jian
    Chang, Cheng
    Obach, R. Scott
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2018 - 2023
  • [23] Drug Design and Success of Prospective Mouse In Vitro-In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CLp) from Hepatocyte Intrinsic Clearance (CLint)
    Manevski, Nenad
    Umehara, Kenichi
    Parrott, Neil
    MOLECULAR PHARMACEUTICS, 2023, 20 (07) : 3438 - 3459
  • [24] In vitro-in vivo Pharmacokinetic correlation model for quality assurance of antiretroviral drugs
    Rojas Gomez, Ricardo
    Restrepo Valencia, Piedad
    COLOMBIA MEDICA, 2015, 46 (03): : 109 - 116
  • [25] Utility of Chimeric Mice with Humanized Liver for Predicting Human Pharmacokinetics in Drug Discovery: Comparison with in Vitro-in Vivo Extrapolation and Allometric Scaling
    Naritomi, Yoichi
    Sanoh, Seigo
    Ohta, Shigeru
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (03) : 327 - 336
  • [26] Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling
    Choi, Go-Wun
    Lee, Yong-Bok
    Cho, Hea-Young
    PHARMACEUTICS, 2019, 11 (04):
  • [27] CYP2B6 Pharmacogenetics-Based In Vitro-In Vivo Extrapolation of Efavirenz Clearance by Physiologically Based Pharmacokinetic Modeling
    Xu, Cong
    Quinney, Sara K.
    Guo, Yingying
    Hall, Stephen D.
    Li, Lang
    Desta, Zeruesenay
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2004 - 2011
  • [28] A Model Mechanism-Based Explanation of an In Vitro-In Vivo Disconnect for Improving Extrapolation and Translation
    Smith, Andrew K.
    Xu, Yanli
    Ropella, Glen E. P.
    Hunt, C. Anthony
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 365 (01) : 127 - 138
  • [29] A Simple Physiologically Based Toxicokinetic Model for Multi-Route In Vitro-In Vivo Extrapolation
    Wambaugh, John F.
    Schacht, Celia M.
    Ring, Caroline L.
    ENVIRONMENTAL SCIENCE & TECHNOLOGY LETTERS, 2025, 12 (03): : 261 - 268
  • [30] Human and animal hepatocytes in vitro with extrapolation in vivo
    O'Brien, PJ
    Chan, K
    Silber, PM
    CHEMICO-BIOLOGICAL INTERACTIONS, 2004, 150 (01) : 97 - 114